Bixiye
QP63-23 MHCP Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective August 1, 2023
Taariikhda dhaqangalka Barnaamijka: Jul 12, 2023
Natiijooyinka Raadinta
Soo bandhiga 1391 - 1400 ee natiijooyinka 3685
Bixiye
QP64-23 Medical Drug Update for New to Market Valoctocogene Roxaparvovec (Roctavian, f.k.a. Valrox)
Taariikhda dhaqangalka Barnaamijka: Jul 12, 2023
Macluumaadka Maaliyadda
Bixiye
commercial-em-007-critical-care-services.pdf
Bixiye
QP67-23 Commercial Pharmacy Benefit Exclusion for Select Medications
Taariikhda barnaamijka Dhaqangalayso Agosto 09, 2023
Bixiye
QP68-23 MHCP Pharmacy Benefit Exclusion for Columvi™, Elevidys, Rystiggo®, and Vyvgart® Hytrulo
Taariikhda barnaamijka Dhaqangalayso Agosto 09, 2023
Bixiye
2023 August Bulletins
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2023
Bixiye
QP65-23 New Medical Coding Pattern Education Program
Taariikhda dhaqangalka Barnaamijka: Jul 26, 2023
Bixiye
QP66-23 Commercial Pharmacy Benefit Exclusion for Elevidys, Rystiggo®, and Vyvgart® Hytrulo
Taariikhda barnaamijka Dhaqangalayso Agosto 09, 2023
Bixiye
P52-23 Updated Minnesota Health Care Programs (MHCP) and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Taariikhda dhaqangalka Barnaamijka: Jul 03, 2023
Bixiye
2023 July Bulletins
Taariikhda dhaqangalka Barnaamijka: Jul 03, 2023